The anti-clotting drug Plavix must now carry a “black box” warning on its label, alerting patients and doctors that some people don’t metabolize the medication properly, U.S. health officials said Friday. Patients with a certain genetic variation can’t convert the blood thinner into its active form, which puts them at risk for heart attack and [...]
Continue reading...
Saturday, March 13, 2010
0 Comments